Perspective Therapeutics Inc (CATX)

[stealthways]

In this instance unlike his other manipulations, he has gone against a flawless study and the only thing he has come up with is that management failed to disclose something that they are NOT required to disclose. This time, it is clear without a doubt that Feuhhrstein is attempting to damage share price. And only that. He is a Hack, and has taken Cramer's rag to new Lows..... Less

by redhtchillipepper @yahooBoard .....

well put.......I add also that unlike other manipulations ISR is strong enough to withstand the bashing since they do not need financing. Other biotech's they used these tactics on can get fought in a "financing trap" since when they knock they share price down and they are running out of money they need to do a financing at a very low share price, which massively dilutes and brings on a ton of selling which is a vicious circle...ISR lucily is not in this type of trap...